INTRODUCTION
Aglobal survey exposed that “fear of needles/injections/pain”, and “safety and side effects” were patients’ main barriers when seeking aesthetic procedures, while aesthetic physicians underestimated these as patient concerns.1 Skin rejuvenation procedures provide notable and desirable aesthetic results; however, patient discomfort and downtime reduce the likelihood that patients seek and/or complete the recommended treatment series.
The lower eyelid skin is a common area of concern as photoaging, visibly manifested as laxity, wrinkles, and pigmentation, appears earlier on the eyelids versus adjacent facial skin. Contour Tunable Resurfacing Laser™ (TRL) (Sciton, Inc., Palo Alto, CA) is an erbium: yttrium aluminum garnet (YAG) fully ablative laser that offers control over the depth of ablation and coagulation.2,3 Recommended Contour TRL™ post-procedure care includes a 48-hour application of petroleum jelly. A study on 7 subjects revealed that the average pain score post-Contour TRL was 4.0 out of 10 (0 = none, 10 = intolerable), with a downtime of 7 to 10 days and adverse effects included edema, erythema, and flaking.4
A topical skincare treatment that can be incorporated immediately post-procedure to alleviate patient discomfort, while enhancing skin recovery and reducing downtime is an unmet need. Addressing patient barriers to skin rejuvenation procedures may improve patient compliance while improving recovery time.
The skin is highly innervated with sensory receptors expressed on keratinocytes and sensory neurons that detect chemical, mechanical, and thermal stimuli, and relay this information to the brain through the skin-brain axis.5 Neurocosmetic ingredients modulate communication by activating or reducing the transmission of sensory information from the skin to the brain.6 A breathable, semi-occlusive, gas-permeable, skin lipid-based post-procedure cream (PPC) was formulated with phytocompounds that directly stimulate communication between the nervous system and the skin. The PPC, containing proprietary unique neurocosmetic technology, a postbiotic, and lipophilic and hydrophilic hydrators was developed to address and ameliorate patient barriers in seeking and completing aesthetic rejuvenation procedures.
The lower eyelid skin is a common area of concern as photoaging, visibly manifested as laxity, wrinkles, and pigmentation, appears earlier on the eyelids versus adjacent facial skin. Contour Tunable Resurfacing Laser™ (TRL) (Sciton, Inc., Palo Alto, CA) is an erbium: yttrium aluminum garnet (YAG) fully ablative laser that offers control over the depth of ablation and coagulation.2,3 Recommended Contour TRL™ post-procedure care includes a 48-hour application of petroleum jelly. A study on 7 subjects revealed that the average pain score post-Contour TRL was 4.0 out of 10 (0 = none, 10 = intolerable), with a downtime of 7 to 10 days and adverse effects included edema, erythema, and flaking.4
A topical skincare treatment that can be incorporated immediately post-procedure to alleviate patient discomfort, while enhancing skin recovery and reducing downtime is an unmet need. Addressing patient barriers to skin rejuvenation procedures may improve patient compliance while improving recovery time.
The skin is highly innervated with sensory receptors expressed on keratinocytes and sensory neurons that detect chemical, mechanical, and thermal stimuli, and relay this information to the brain through the skin-brain axis.5 Neurocosmetic ingredients modulate communication by activating or reducing the transmission of sensory information from the skin to the brain.6 A breathable, semi-occlusive, gas-permeable, skin lipid-based post-procedure cream (PPC) was formulated with phytocompounds that directly stimulate communication between the nervous system and the skin. The PPC, containing proprietary unique neurocosmetic technology, a postbiotic, and lipophilic and hydrophilic hydrators was developed to address and ameliorate patient barriers in seeking and completing aesthetic rejuvenation procedures.
